Phase II Trial of Neoadjuvant Dose-Dense Doxorubicin, Ifosfamide, and Irinotecan (CPT-11) for Advanced Soft Tissue and Recurrent Bone Sarcomas.
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Dexrazoxane (Primary) ; Doxorubicin; Ifosfamide; Irinotecan
- Indications Ewing's sarcoma; Neuroectodermal tumours; Osteosarcoma; Sarcoma; Soft tissue sarcoma
- Focus Therapeutic Use
- 17 Oct 2011 Planned end date (1 Oct 2012) added as reported by ClinicalTrials.gov.
- 13 Nov 2007 New trial record.